{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:36:39Z","timestamp":1793979399153,"version":"4.8.0"},"reference-count":137,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"DOI":"10.1007\/s00280-025-04835-z","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T06:10:19Z","timestamp":1766988619000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Curcumin in colorectal cancer: preventive strategies and therapeutic mechanisms"],"prefix":"10.1007","volume":"96","author":[{"given":"Amit","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavin","family":"Parekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usamah","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renuka","family":"Jyothi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya Priyadarshini","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish Singh","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siya","family":"Singla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"issue":"9","key":"4835_CR1","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/j.cgh.2018.09.038","volume":"17","author":"NJ Samadder","year":"2019","unstructured":"Samadder NJ, Valentine JF, Guthery S, Singh H, Bernstein CN, Leighton JA et al (2019) Family history associates with increased risk of colorectal cancer in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol 17(9):1807\u201313e1","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4835_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14071732","author":"MS Hossain","year":"2022","unstructured":"Hossain MS, Karuniawati H, Jairoun AA, Urbi Z, Ooi DJ, John A et al (2022) Colorectal cancer: a review of carcinogenesis, global epidemiology, current challenges, risk factors, preventive and treatment strategies. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers14071732","journal-title":"Cancers (Basel)"},{"key":"4835_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032137","author":"F Rebuzzi","year":"2023","unstructured":"Rebuzzi F, Ulivi P, Tedaldi G (2023) Genetic predisposition to colorectal cancer: how many and which genes to test? Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24032137","journal-title":"Int J Mol Sci"},{"key":"4835_CR4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.amsu.2021.01.017","volume":"62","author":"FZ Outtaleb","year":"2021","unstructured":"Outtaleb FZ, Alami A, Serbati N, Benchakroun N, Bouchbika Z, Jouhadi H et al (2021) Lynch syndrome or hereditary non polyposis colorectal cancer (HNPCC) in a Moroccan family: case report. Ann Med Surg (Lond) 62:123\u2013126","journal-title":"Ann Med Surg (Lond)"},{"key":"4835_CR5","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1747326","volume":"2022","author":"GH Yu","year":"2022","unstructured":"Yu GH, Li SF, Wei R, Jiang Z (2022) Diabetes and colorectal cancer risk: clinical and therapeutic implications. J Diabetes Res 2022:1747326","journal-title":"J Diabetes Res"},{"key":"4835_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13092025","author":"T Sawicki","year":"2021","unstructured":"Sawicki T, Ruszkowska M, Danielewicz A, Nied\u017awiedzka E, Ar\u0142ukowicz T, Przyby\u0142owicz KE (2021) A review of colorectal cancer in terms of epidemiology, risk factors, development, symptoms and diagnosis. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13092025","journal-title":"Cancers (Basel)"},{"key":"4835_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d6617","volume":"343","author":"D Aune","year":"2011","unstructured":"Aune D, Chan DS, Lau R, Vieira R, Greenwood DC, Kampman E et al (2011) Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. BMJ 343:d6617","journal-title":"BMJ"},{"issue":"13","key":"4835_CR8","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1056\/NEJMoa1713709","volume":"378","author":"A Grothey","year":"2018","unstructured":"Grothey A, Sobrero AF, Shields AF, Yoshino T, Paul J, Taieb J et al (2018) Duration of adjuvant chemotherapy for stage III colon cancer. N Engl J Med 378(13):1177\u20131188","journal-title":"N Engl J Med"},{"issue":"4","key":"4835_CR9","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.gendis.2022.02.007","volume":"10","author":"U Anand","year":"2023","unstructured":"Anand U, Dey A, Chandel AKS, Sanyal R, Mishra A, Pandey DK et al (2023) Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics. Genes Dis 10(4):1367\u20131401","journal-title":"Genes Dis"},{"key":"4835_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13030642","author":"SH Shaham","year":"2025","unstructured":"Shaham SH, Vij P, Tripathi MK (2025) Advances in targeted and chemotherapeutic strategies for colorectal cancer: current insights and future directions. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines13030642","journal-title":"Biomedicines"},{"issue":"2","key":"4835_CR11","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.3390\/molecules20022728","volume":"20","author":"MK Shanmugam","year":"2015","unstructured":"Shanmugam MK, Rane G, Kanchi MM, Arfuso F, Chinnathambi A, Zayed ME et al (2015) The multifaceted role of curcumin in cancer prevention and treatment. Molecules 20(2):2728\u20132769","journal-title":"Molecules"},{"key":"4835_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26041109","author":"CA Dehelean","year":"2021","unstructured":"Dehelean CA, Marcovici I, Soica C, Mioc M, Coricovac D, Iurciuc S et al (2021) Plant-derived anticancer compounds as new perspectives in drug discovery and alternative therapy. Molecules. https:\/\/doi.org\/10.3390\/molecules26041109","journal-title":"Molecules"},{"issue":"2","key":"4835_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/ijc.23097","volume":"122","author":"BB Patel","year":"2008","unstructured":"Patel BB, Sengupta R, Qazi S, Vachhani H, Yu Y, Rishi AK et al (2008) Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-1R. Int J Cancer 122(2):267\u2013273","journal-title":"Int J Cancer"},{"key":"4835_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.semcancer.2020.02.011","volume":"80","author":"W Weng","year":"2022","unstructured":"Weng W, Goel A (2022) Curcumin and colorectal cancer: an update and current perspective on this natural medicine. Semin Cancer Biol 80:73\u201386","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"4835_CR15","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"key":"4835_CR16","unstructured":"Sharma R, Abbasi-Kangevari M, Abd-Rabu R, Abidi H, Abu-Gharbieh E, Acuna JM et al (2022) Global, regional, and National burden of colorectal cancer and its risk factors, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. The lancet Gastroenterology & hepatology"},{"key":"4835_CR17","doi-asserted-by":"crossref","unstructured":"Huang J, Patel H, Lucero-Prisno D, Boakye D, Chandrasekar V, Lok V et al (2020) IDDF2020-ABS-0181\u2005Disease burden, risk factors, and recent trends of colorectal cancer: a global analysis of data from 186 countries. Abstracts","DOI":"10.1136\/gutjnl-2020-IDDF.8"},{"key":"4835_CR18","unstructured":"Li J, Zhang Y, Ji Y, Wu J, Jin Q, Feng Z et al (2025) [Comparison analyses of global burden of colorectal cancer]. Zhonghua Zhong Liu Za Zhi [Chinese journal of oncology]. 47 4:308\u2013315"},{"key":"4835_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.61838\/kman.jodhn.2.3.6","volume":"1","author":"A Asadi","year":"2025","unstructured":"Asadi A, Ghahramani Y (2025) Gold nanoparticles: a powerful biosensor in oral medicine and dentistry. J Oral Dent Health Nexus 1:1\u20134","journal-title":"J Oral Dent Health Nexus"},{"key":"4835_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1524308","author":"Y Deng","year":"2025","unstructured":"Deng Y, Wang Y, Yang J, Luo X, Qiu J, Long R et al (2025) Global, regional, and national disease burden and prediction analysis of colorectal cancer attributable to tobacco, alcohol, and obesity from 1990 to 2030. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2025.1524308","journal-title":"Front Oncol"},{"key":"4835_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-025-04817-w","author":"M He","year":"2025","unstructured":"He M, Gu R, Huang X, Zhao A, Tian S, Zheng Y (2025) Global burden of colorectal cancer attributable to metabolic risks from 1990 to 2021, with projections of mortality to 2035. Int J Colorectal Dis. https:\/\/doi.org\/10.1007\/s00384-025-04817-w","journal-title":"Int J Colorectal Dis"},{"issue":"2","key":"4835_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3393\/ac.2024.00059.0008","volume":"40","author":"HS Ryu","year":"2024","unstructured":"Ryu HS, Kim HJ, Ji WB, Kim BC, Kim JH, Moon SK et al (2024) Colon cancer: the 2023 Korean clinical practice guidelines for diagnosis and treatment. Ann Coloproctol 40(2):89\u2013113","journal-title":"Ann Coloproctol"},{"issue":"2","key":"4835_CR23","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","volume":"72","author":"E Morgan","year":"2023","unstructured":"Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag CJ, Laversanne M et al (2023) Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut 72(2):338\u2013344","journal-title":"Gut"},{"key":"4835_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076651","author":"I Ahmad","year":"2023","unstructured":"Ahmad I, Hoque M, Alam SSM, Zughaibi T, Tabrez S (2023) Curcumin and Plumbagin synergistically target the PI3K\/Akt\/mTOR pathway: a prospective role in cancer treatment. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24076651","journal-title":"Int J Mol Sci"},{"issue":"5","key":"4835_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-024-02327-3","volume":"41","author":"A Soroush","year":"2024","unstructured":"Soroush A, Pourhossein S, Hosseingholizadeh D, Hjazi A, Shahhosseini R, Kavoosi H, Kermanshahi N, Behnamrad P, Ghavamikia N, Dadashpour M, Karkon Shayan S (2024) Anti-cancer potential of Zerumbone in cancer and glioma: current trends and future perspectives. Med Oncol 41(5):125","journal-title":"Med Oncol"},{"key":"4835_CR26","doi-asserted-by":"crossref","unstructured":"Atwan QS, Al-Ogaidi I (2024) Enhancing the therapeutic potential of curcumin: a novel nanoformulation for targeted anticancer therapy to colorectal cancer with reduced miR20a and miR21 expression. Biomed Mater. ;19(2)","DOI":"10.1088\/1748-605X\/ad1dfc"},{"key":"4835_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27113470","author":"HJ Azeez","year":"2022","unstructured":"Azeez HJ, Neri F, Hosseinpour Feizi MA, Babaei E (2022) Transcriptome profiling of HCT-116 colorectal cancer cells with RNA sequencing reveals novel targets for polyphenol nano Curcumin. Molecules. https:\/\/doi.org\/10.3390\/molecules27113470","journal-title":"Molecules"},{"issue":"1","key":"4835_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-83938-y","volume":"11","author":"A Bernardo","year":"2021","unstructured":"Bernardo A, Plumitallo C, De Nuccio C, Visentin S, Minghetti L (2021) Curcumin promotes oligodendrocyte differentiation and their protection against TNF-\u03b1 through the activation of the nuclear receptor PPAR-\u03b3. Sci Rep 11(1):4952","journal-title":"Sci Rep"},{"issue":"7","key":"4835_CR29","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1002\/ptr.8220","volume":"38","author":"A Brockmueller","year":"2024","unstructured":"Brockmueller A, Ruiz de Porras V, Shakibaei M (2024) Curcumin and its anti-colorectal cancer potential: from mechanisms of action to autophagy. Phytother Res 38(7):3525\u20133551","journal-title":"Phytother Res"},{"issue":"2","key":"4835_CR30","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1080\/01635581.2022.2139398","volume":"75","author":"M Chen","year":"2023","unstructured":"Chen M, Tan AH, Li J (2023) Curcumin represses colorectal cancer cell proliferation by triggering ferroptosis via PI3K\/Akt\/mTOR signaling. Nutr Cancer 75(2):726\u2013733","journal-title":"Nutr Cancer"},{"issue":"11","key":"4835_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-023-02191-7","volume":"40","author":"SA Noraldeen","year":"2023","unstructured":"Noraldeen SA, Rasulova I, Lalitha R, Hussin F, Alsaab HO, Alawadi AH, Alsaalamy A, Sayyid NH, Alkhafaji AT, Mustafa YF, Shayan SK (2023) Involving stemness factors to improve CAR T-cell-based cancer immunotherapy. Med Oncol 40(11):313","journal-title":"Med Oncol"},{"issue":"1","key":"4835_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/biof.2137","volume":"51","author":"HY Chuang","year":"2025","unstructured":"Chuang HY, Chan HW, Shih KC (2025) Suppression of colorectal cancer growth: interplay between Curcumin and Metformin through DMT1 downregulation and ROS-mediated pathways. Biofactors 51(1):e2137","journal-title":"Biofactors"},{"issue":"4","key":"4835_CR33","doi-asserted-by":"publisher","first-page":"883","DOI":"10.55730\/1300-0144.5652","volume":"53","author":"A Dal Z","year":"2023","unstructured":"Dal Z A, Aru B (2023) The role of curcumin on apoptosis and NLRP3 inflammasome-dependent pyroptosis on colorectal cancer in vitro. Turk J Med Sci 53(4):883\u2013893","journal-title":"Turk J Med Sci"},{"issue":"12","key":"4835_CR34","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.2174\/1871520618666180604093802","volume":"18","author":"L Das","year":"2019","unstructured":"Das L, Vinayak M (2019) Curcumin modulates glycolytic metabolism and inflammatory cytokines via Nrf 2 in dalton\u2019s lymphoma ascites cells in vivo. Anti-Cancer Agents Med Chem 18(12):1779\u20131791","journal-title":"Anti-Cancer Agents Med Chem"},{"key":"4835_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.8258","author":"T Ming","year":"2024","unstructured":"Ming T, Lei J, Peng Y, Wang M, Liang Y, Tang S et al (2024) Curcumin suppresses colorectal cancer by induction of ferroptosis via regulation of p53 and solute carrier family 7 member 11\/glutathione\/glutathione peroxidase 4 signaling axis. Phytother Res. https:\/\/doi.org\/10.1002\/ptr.8258","journal-title":"Phytother Res"},{"key":"4835_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16081554","author":"V Zoi","year":"2024","unstructured":"Zoi V, Kyritsis A, Galani V, Lazari D, Sioka C, Voulgaris S et al (2024) The role of curcumin in cancer: a focus on the PI3K\/Akt pathway. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers16081554","journal-title":"Cancers (Basel)"},{"key":"4835_CR37","doi-asserted-by":"publisher","DOI":"10.2174\/0113816128263974231029180947","author":"Q Li","year":"2023","unstructured":"Li Q, Ding Y, Ou Y, Li M, Jithavech P, Buranasudja V et al (2023) Curcuminoids modulated the IL-6\/JAK\/STAT3 signaling pathway in LoVo and HT-29 colorectal cancer cells. Curr Pharm Des. https:\/\/doi.org\/10.2174\/0113816128263974231029180947","journal-title":"Curr Pharm Des"},{"key":"4835_CR38","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/3619510","volume":"2021","author":"M Pashirzad","year":"2021","unstructured":"Pashirzad M, Johnston TP, Sahebkar A (2021) Therapeutic effects of polyphenols on the treatment of colorectal cancer by regulating Wnt \u03b2-catenin signaling pathway. J Oncol 2021:3619510","journal-title":"J Oncol"},{"key":"4835_CR39","first-page":"539","volume":"17","author":"X-j Qian","year":"2021","unstructured":"Qian X-j, Jiang C, Zhu Z, Han G, Wang R-s, Zhang C (2021) Curcumin mediates the proliferation and apoptosis of colorectal cancer cells by downregulating the expression of interleukin-1\u03b2 through the nuclear factor-\u03baB signaling pathway. Pharmacogn Mag 17:539\u2013544","journal-title":"Pharmacogn Mag"},{"issue":"2","key":"4835_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-024-02560-w","volume":"42","author":"DK Sabir","year":"2025","unstructured":"Sabir DK (2025) Targeting the Hippo and Rap1 signaling pathways: the anti-proliferative effects of Curcumin in colorectal cancer cell lines. Med Oncol 42(2):41","journal-title":"Med Oncol"},{"issue":"2","key":"4835_CR41","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1080\/01635581.2021.1884730","volume":"74","author":"H Villota","year":"2022","unstructured":"Villota H, R\u00f6thlisberger S, Pedroza-D\u00edaz J (2022) Modulation of the canonical Wnt signaling pathway by dietary polyphenols, an opportunity for colorectal cancer chemoprevention and treatment. Nutr Cancer 74(2):384\u2013404","journal-title":"Nutr Cancer"},{"issue":"3","key":"4835_CR42","doi-asserted-by":"publisher","DOI":"10.1111\/cbdd.14468","volume":"103","author":"W Xin","year":"2024","unstructured":"Xin W, Zhang Y (2024) Curcumin activates the JNK signaling pathway to promote ferroptosis in colon cancer cells. Chem Biol Drug Des 103(3):e14468","journal-title":"Chem Biol Drug Des"},{"key":"4835_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2021.155541","author":"A Gorabi","year":"2021","unstructured":"Gorabi A, Razi B, Aslani S, Abbasifard M, Imani D, Sathyapalan T et al (2021) Effect of curcumin on proinflammatory cytokines: a meta-analysis of randomized controlled trials. Cytokine. https:\/\/doi.org\/10.1016\/j.cyto.2021.155541","journal-title":"Cytokine"},{"key":"4835_CR44","doi-asserted-by":"crossref","unstructured":"Setyono J, Harini I, Sarmoko S, Rujito L (2019) Supplementation of curcuma domestica extract reduces cox-2 and inos expression on raw 264.7 cells. Journal of Physics: Conference Series. ;1246","DOI":"10.1088\/1742-6596\/1246\/1\/012059"},{"key":"4835_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/medicina55040090","author":"S Hosseini","year":"2019","unstructured":"Hosseini S, Zand H, Cheraghpour M (2019) The influence of curcumin on the downregulation of MYC, insulin and IGF-1 receptors: a possible mechanism underlying the anti-growth and anti-migration in chemoresistant colorectal cancer cells. Medicina (B Aires). https:\/\/doi.org\/10.3390\/medicina55040090","journal-title":"Medicina (B Aires)"},{"issue":"39","key":"4835_CR46","doi-asserted-by":"publisher","first-page":"4626","DOI":"10.2174\/1381612825666190110145151","volume":"24","author":"R Moradi-Marjaneh","year":"2019","unstructured":"Moradi-Marjaneh R, Hassanian S, Rahmani F, Aghaee-Bakhtiari S, Avan A, Khazaei M (2019) Phytosomal curcumin elicits anti-tumor properties through suppression of angiogenesis, cell proliferation and induction of oxidative stress in colorectal cancer. Curr Pharm Des 24(39):4626\u20134638","journal-title":"Curr Pharm Des"},{"key":"4835_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120592","author":"M Ebrahimi","year":"2021","unstructured":"Ebrahimi M, Babaei E, Neri F, Feizi M (2021) Anti-proliferative and apoptotic effect of gemini curcumin in p53-wild type and p53-mutant colorectal cancer cell lines. Int J Pharm. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120592","journal-title":"Int J Pharm"},{"issue":"7","key":"4835_CR48","first-page":"3080","volume":"23","author":"H Shang","year":"2019","unstructured":"Shang H, Wang T, Shang F, Li M, Luo Y, Huang K (2019) Over-expression of DJ-1 attenuates effects of curcumin on colorectal cancer cell proliferation and apoptosis. Eur Rev Med Pharmacol Sci 23(7):3080\u20133087","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"4835_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.139306","author":"MF Malekzada","year":"2024","unstructured":"Malekzada MF, Mosawi SH, Fani N, Nazir S (2024) Integrating molecular docking and molecular dynamics simulation approaches for investigation of the affinity and interactions of the Curcumin with phosphatase and tensin homolog (PTEN) and mutated PTEN. J Mol Struct. https:\/\/doi.org\/10.1016\/j.molstruc.2024.139306","journal-title":"J Mol Struct"},{"key":"4835_CR50","doi-asserted-by":"publisher","DOI":"10.17650\/2949-5857-2023-13-4-17-37","author":"A Orekhva","year":"2024","unstructured":"Orekhva A, Shlyakhtunov E, Semenov V, Zhiltsov I, Erushevich A, Shappo G et al (2024) Clinical significance of survivin mRNA expression (BIRC5) in colorectal cancer. Surg Oncol. https:\/\/doi.org\/10.17650\/2949-5857-2023-13-4-17-37","journal-title":"Surg Oncol"},{"key":"4835_CR51","doi-asserted-by":"crossref","unstructured":"Han W, Yin H, Haoyue, Wang Y, Kong D, Fan Z (2020) Curcumin Regulates ERCC1 Expression and Enhances Oxaliplatin Sensitivity in Resistant Colorectal Cancer Cells through Its Effects on miR-409-3p. Evidence-based Complementary and Alternative Medicine: eCAM. ;2020","DOI":"10.1155\/2020\/8394574"},{"issue":"13","key":"4835_CR52","first-page":"2191","volume":"38","author":"Ld Guo","year":"2013","unstructured":"Guo Ld, Jiao Z, Song Y, Teng W, Liu Z, Liu J-Z (2013) Study on functions and mechanism of Curcumin in inducing colorectal carcinoma cells LoVo apoptosis. Zhongguo Zhong Yao Za zhi\u2009=\u2009Zhongguo Zhongyao Zazhi\u2009=\u2009China. J Chin Materia Med 38(13):2191\u20132196","journal-title":"Zhongguo Zhong Yao Za zhi\u2009=\u2009Zhongguo Zhongyao Zazhi\u2009=\u2009China. J Chin Materia Med"},{"issue":"3","key":"4835_CR53","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2021.12447","volume":"21","author":"J Hao","year":"2021","unstructured":"Hao J, Dai X, Gao J, Li Y, Hou Z, Chang Z et al (2021) Curcumin suppresses colorectal tumorigenesis via the Wnt\/\u03b2-catenin signaling pathway by downregulating Axin2. Oncol Lett 21(3):186","journal-title":"Oncol Lett"},{"issue":"5","key":"4835_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0216711","volume":"14","author":"X Lin","year":"2019","unstructured":"Lin X, Bai D, Wei Z, Zhang Y, Huang Y, Deng H et al (2019) Curcumin attenuates oxidative stress in RAW264.7 cells by increasing the activity of antioxidant enzymes and activating the Nrf2-Keap1 pathway. PLoS ONE 14(5):e0216711","journal-title":"PLoS ONE"},{"key":"4835_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.644197","author":"H Wang","year":"2021","unstructured":"Wang H, Xu Y, Sun J, Sui Z (2021) The novel curcumin derivative 1 g induces mitochondrial and ER-stress-dependent apoptosis in colon cancer cells by induction of ROS production. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2021.644197","journal-title":"Front Oncol"},{"key":"4835_CR56","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00209.2004","volume":"288","author":"A Chen","year":"2005","unstructured":"Chen A, Xu J (2005) Activation of PPAR{gamma} by curcumin inhibits moser cell growth and mediates suppression of gene expression of Cyclin D1 and EGFR. Am J Physiol Gastrointest Liver Physiol 288:3","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"4835_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2024.101942","volume":"72","author":"N Grellier","year":"2024","unstructured":"Grellier N, Severino A, Archilei S, Kim J, Gasbarrini A, Cammarota G et al (2024) Gut microbiota in inflammation and colorectal cancer: a potential toolbox for clinicians. Best Pract Res Clin Gastroenterol 72:101942","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"1","key":"4835_CR58","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1080\/0886022X.2021.1944875","volume":"43","author":"X Xu","year":"2021","unstructured":"Xu X, Wang H, Guo D, Man X, Liu J, Li J et al (2021) Curcumin modulates gut microbiota and improves renal function in rats with uric acid nephropathy. Ren Fail 43(1):1063\u20131075","journal-title":"Ren Fail"},{"issue":"11","key":"4835_CR59","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1097\/CM9.0000000000003617","volume":"138","author":"Z Kang","year":"2025","unstructured":"Kang Z, Jiang S, Fang JY, Chen H (2025) Intestinal dysbiosis and colorectal cancer. Chin Med J (Engl) 138(11):1266\u20131287","journal-title":"Chin Med J (Engl)"},{"key":"4835_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/life14050559","author":"S Facchin","year":"2024","unstructured":"Facchin S, Bertin L, Bonazzi E, Lorenzon G, De Barba C, Barberio B et al (2024) Short-chain fatty acids and human health: from metabolic pathways to current therapeutic implications. Life (Basel). https:\/\/doi.org\/10.3390\/life14050559","journal-title":"Life (Basel)"},{"issue":"11","key":"4835_CR61","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1097\/MIB.0000000000000522","volume":"21","author":"RM McFadden","year":"2015","unstructured":"McFadden RM, Larmonier CB, Shehab KW, Midura-Kiela M, Ramalingam R, Harrison CA et al (2015) The role of Curcumin in modulating colonic microbiota during colitis and colon cancer prevention. Inflamm Bowel Dis 21(11):2483\u20132494","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"4835_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-09054-2","volume":"21","author":"M Rebersek","year":"2021","unstructured":"Rebersek M (2021) Gut microbiome and its role in colorectal cancer. BMC Cancer 21(1):1325","journal-title":"BMC Cancer"},{"issue":"1","key":"4835_CR63","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2483780","volume":"17","author":"B Thulasinathan","year":"2025","unstructured":"Thulasinathan B, Suvilesh KN, Maram S, Grossmann E, Ghouri Y, Teixeiro EP et al (2025) The impact of gut microbial short-chain fatty acids on colorectal cancer development and prevention. Gut Microbes 17(1):2483780","journal-title":"Gut Microbes"},{"key":"4835_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104943","author":"HS Sardou","year":"2023","unstructured":"Sardou HS, Nazari S, Abbaspour M, Akhgari A, Sheikh A, Kesharwani P et al (2023) Nano-curcumin formulations for targeted therapy of colorectal cancer. J Drug Deliv Sci Technol. https:\/\/doi.org\/10.1016\/j.jddst.2023.104943","journal-title":"J Drug Deliv Sci Technol"},{"issue":"5","key":"4835_CR65","doi-asserted-by":"publisher","first-page":"599","DOI":"10.2174\/0113892010242028231002075512","volume":"25","author":"R Deshmukh","year":"2024","unstructured":"Deshmukh R, Prajapati M, Harwansh R (2024) Management of colorectal cancer using nanocarriers-based drug delivery for herbal bioactives: current and emerging approaches. Curr Pharm Biotechnol 25(5):599\u2013622","journal-title":"Curr Pharm Biotechnol"},{"key":"4835_CR66","first-page":"1","volume":"40","author":"AF Amandi","year":"2023","unstructured":"Amandi AF, Jokar E, Eslami M, Dadashpour M, Rezaie M, Yazdani Y et al (2023) Enhanced anti-cancer effect of artemisinin- and curcumin-loaded Niosomal nanoparticles against human colon cancer cells. Med Oncol 40:1\u20139","journal-title":"Med Oncol"},{"key":"4835_CR67","unstructured":"Potraje ACPAC, Zade BYZBY, Gujatwar APGAP, Chachda NCD (2024) Review on different Preparation methods used for dvelopment of Curcumin nanoparticles. Int J Pharm Res Appl"},{"key":"4835_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e05360","author":"L Al-Ani","year":"2020","unstructured":"Al-Ani L, Kadir F, Hashim N, Julkapli N, Seyfoddin A, Lu J et al (2020) The impact of curcumin-graphene based nanoformulation on cellular interaction and redox-activated apoptosis: an in vitro colon cancer study. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e05360","journal-title":"Heliyon"},{"key":"4835_CR69","first-page":"79","volume":"30","author":"A Asadi","year":"2025","unstructured":"Asadi A, Khaksar E, Hosseinpoor S, Abbasi R, Ghahramani Y (2025) Aluminum Nanoparticles, a new approach in sustainable chemistry and usage in Medicine. Advances in applied Nano-Bio technologies. Jun 30:79\u201391","journal-title":"Jun"},{"key":"4835_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15020657","author":"EA Madawi","year":"2023","unstructured":"Madawi EA, Al Jayoush AR, Rawas-Qalaji M, Thu HE, Khan S, Sohail M et al (2023) Polymeric nanoparticles as tunable nanocarriers for targeted delivery of drugs to skin tissues for treatment of topical skin diseases. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics15020657","journal-title":"Pharmaceutics"},{"key":"4835_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/nano9091246","volume":"9","author":"N Kotla","year":"2019","unstructured":"Kotla N, Burke O, Pandit A, Rochev Y (2019) An orally administrated hyaluronan functionalized polymeric hybrid nanoparticle system for colon-specific drug delivery. Nanomaterials 9:1246","journal-title":"Nanomaterials"},{"issue":"17","key":"4835_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179652","volume":"22","author":"V Miku\u0161ov\u00e1","year":"2021","unstructured":"Miku\u0161ov\u00e1 V, Miku\u0161 P (2021) Advances in chitosan-based nanoparticles for drug delivery. Int J Mol Sci 22(17):9652","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4835_CR73","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1021\/acs.bioconjchem.9b00006","volume":"30","author":"AJ van der Vlies","year":"2019","unstructured":"van der Vlies AJ, Morisaki M, Neng HI, Hansen EM, Hasegawa U (2019) Framboidal nanoparticles containing a Curcumin-Phenylboronic acid complex with antiangiogenic and anticancer activities. Bioconjug Chem 30(3):861\u2013870","journal-title":"Bioconjug Chem"},{"key":"4835_CR74","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.toxrep.2022.04.017","volume":"9","author":"S Mahalanobish","year":"2022","unstructured":"Mahalanobish S, Kundu M, Ghosh S, Das J, Sil PC (2022) Fabrication of phenyl boronic acid modified pH-responsive zinc oxide nanoparticles as targeted delivery of Chrysin on human A549 cells. Toxicol Rep 9:961\u2013969","journal-title":"Toxicol Rep"},{"key":"4835_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.121594","volume":"617","author":"D Andr\u00e9s Real","year":"2022","unstructured":"Andr\u00e9s Real D, Gagliano A, Sonsini N, Wicky G, Orzan L, Leonardi D et al (2022) Design and optimization of pH-sensitive Eudragit nanoparticles for improved oral delivery of triclabendazole. Int J Pharm 617:121594","journal-title":"Int J Pharm"},{"issue":"1","key":"4835_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01849-0","volume":"22","author":"KR Gajbhiye","year":"2023","unstructured":"Gajbhiye KR, Salve R, Narwade M, Sheikh A, Kesharwani P, Gajbhiye V (2023) Lipid polymer hybrid nanoparticles: a custom-tailored next-generation approach for cancer therapeutics. Mol Cancer 22(1):160","journal-title":"Mol Cancer"},{"key":"4835_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodhyd.2022.107532","volume":"129","author":"N Zhang","year":"2022","unstructured":"Zhang N, Han J, Chen F, Gao C, Tang X (2022) Chitosan\/gum Arabic complexes to stabilize Pickering emulsions: relationship between the preparation, structure and oil-water interfacial activity. Food Hydrocolloids 129:107532","journal-title":"Food Hydrocolloids"},{"key":"4835_CR78","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ejpb.2015.03.005","volume":"93","author":"L Mayol","year":"2015","unstructured":"Mayol L, Serri C, Menale C, Crispi S, Piccolo MT, Mita L et al (2015) Curcumin loaded PLGA\u2013poloxamer blend nanoparticles induce cell cycle arrest in mesothelioma cells. Eur J Pharm Biopharm 93:37\u201345","journal-title":"Eur J Pharm Biopharm"},{"key":"4835_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/nano10050847","author":"S Deng","year":"2020","unstructured":"Deng S, Gigliobianco MR, Censi R, Di Martino P (2020) Polymeric nanocapsules as nanotechnological alternative for drug delivery system: current status, challenges and opportunities. Nanomaterials. https:\/\/doi.org\/10.3390\/nano10050847","journal-title":"Nanomaterials"},{"key":"4835_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2019.110550","volume":"109","author":"L Slika","year":"2020","unstructured":"Slika L, Moubarak A, Borjac J, Baydoun E, Patra D (2020) Preparation of Curcumin-poly (allyl amine) hydrochloride based nanocapsules: Piperine in nanocapsules accelerates encapsulation and release of Curcumin and effectiveness against colon cancer cells. Mater Sci Eng C Mater Biol Appl 109:110550","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"36","key":"4835_CR81","doi-asserted-by":"publisher","first-page":"4704","DOI":"10.1002\/smll.201403799","volume":"11","author":"R Klippstein","year":"2015","unstructured":"Klippstein R, Wang JT, El-Gogary RI, Bai J, Mustafa F, Rubio N et al (2015) Passively targeted curcumin-loaded pegylated PLGA nanocapsules for colon cancer therapy in vivo. Small 11(36):4704\u20134722","journal-title":"Small"},{"key":"4835_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14122728","author":"HO Alsaab","year":"2022","unstructured":"Alsaab HO, Alharbi FD, Alhibs AS, Alanazi NB, Alshehri BY, Saleh MA et al (2022) PLGA-based nanomedicine: history of advancement and development in clinical applications of multiple diseases. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics14122728","journal-title":"Pharmaceutics"},{"key":"4835_CR83","doi-asserted-by":"publisher","first-page":"8729","DOI":"10.2147\/IJN.S517079","volume":"20","author":"H Wang","year":"2025","unstructured":"Wang H, Di W, Gao X, Guo Y, Tang T, Bai X et al (2025) Materials, syntheses and biomedical applications of Nano-Quercetin formulations: A comprehensive literature review. Int J Nanomed 20:8729\u20138764","journal-title":"Int J Nanomed"},{"key":"4835_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120628","volume":"602","author":"Y Wang","year":"2021","unstructured":"Wang Y, Ding R, Zhang Z, Zhong C, Wang J, Wang M (2021) Curcumin-loaded liposomes with the hepatic and lysosomal dual-targeted effects for therapy of hepatocellular carcinoma. Int J Pharm 602:120628","journal-title":"Int J Pharm"},{"issue":"5","key":"4835_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e09394","volume":"8","author":"H Nsairat","year":"2022","unstructured":"Nsairat H, Khater D, Sayed U, Odeh F, Al Bawab A, Alshaer W (2022) Liposomes: structure, composition, types, and clinical applications. Heliyon 8(5):e09394","journal-title":"Heliyon"},{"key":"4835_CR86","doi-asserted-by":"publisher","first-page":"8279","DOI":"10.2147\/IJN.S340180","volume":"16","author":"Y Sun","year":"2021","unstructured":"Sun Y, Xie Y, Tang H, Ren Z, Luan X, Zhang Y et al (2021) In vitro and in vivo evaluation of a novel Estrogen-Targeted pegylated oxaliplatin liposome for gastric cancer. Int J Nanomed 16:8279\u20138303","journal-title":"Int J Nanomed"},{"key":"4835_CR87","doi-asserted-by":"publisher","DOI":"10.1177\/15330338241308077","volume":"23","author":"F Ramezani","year":"2024","unstructured":"Ramezani F, Moghadasi M, Shamsasenjan K, Narmani A (2024) Folic acid-decorated chitosan-PLGA nanobiopolymers for targeted drug delivery to acute lymphoblastic leukemia cells: in vitro studies. Technol Cancer Res Treat 23:15330338241308077","journal-title":"Technol Cancer Res Treat"},{"key":"4835_CR88","doi-asserted-by":"publisher","DOI":"10.3390\/gels11020124","author":"L Radeva","year":"2025","unstructured":"Radeva L, Yoncheva K (2025) Nanogels\u2014innovative drug carriers for overcoming biological membranes. Gels. https:\/\/doi.org\/10.3390\/gels11020124","journal-title":"Gels"},{"issue":"1","key":"4835_CR89","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1080\/10717544.2022.2094498","volume":"29","author":"B Li","year":"2022","unstructured":"Li B, Huili S, Lei G, Huan L, Huagang S, Zhu L (2022) Nano-drug co-delivery system of natural active ingredients and chemotherapy drugs for cancer treatment: a review. Drug Deliv 29(1):2130\u20132161","journal-title":"Drug Deliv"},{"key":"4835_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.onano.2022.100036","volume":"6","author":"PS Kumbhar","year":"2022","unstructured":"Kumbhar PS, Nadaf S, Manjappa AS, Jha NK, Shinde SS, Chopade SS et al (2022) D-\u0251-tocopheryl polyethylene glycol succinate: a review of multifarious applications in nanomedicines. OpenNano 6:100036","journal-title":"OpenNano"},{"key":"4835_CR91","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.addr.2020.09.009","volume":"156","author":"D Hwang","year":"2020","unstructured":"Hwang D, Ramsey JD, Kabanov AV (2020) Polymeric micelles for the delivery of poorly soluble drugs: from nanoformulation to clinical approval. Adv Drug Deliv Rev 156:80\u2013118","journal-title":"Adv Drug Deliv Rev"},{"key":"4835_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15102481","author":"T Trimaille","year":"2023","unstructured":"Trimaille T, Verrier B (2023) Copolymer micelles: a focus on recent advances for stimulus-responsive delivery of proteins and peptides. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics15102481","journal-title":"Pharmaceutics"},{"issue":"1","key":"4835_CR93","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ijpharm.2015.08.013","volume":"495","author":"TBT Nguyen","year":"2015","unstructured":"Nguyen TBT, Li S, Deratani A (2015) Reverse micelles prepared from amphiphilic polylactide-b-poly(ethylene glycol) block copolymers for controlled release of hydrophilic drugs. Int J Pharm 495(1):154\u2013161","journal-title":"Int J Pharm"},{"issue":"1","key":"4835_CR94","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/jps.23800","volume":"103","author":"X Yang","year":"2014","unstructured":"Yang X, Cao D, Wang N, Sun L, Li L, Nie S et al (2014) In vitro and in vivo safety evaluation of biodegradable self-assembled monomethyl poly (ethylene glycol)-poly (\u03b5-caprolactone)-poly (trimethylene carbonate) micelles. J Pharm Sci 103(1):305\u2013313","journal-title":"J Pharm Sci"},{"issue":"5","key":"4835_CR95","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-022-02268-y","volume":"23","author":"S Idoudi","year":"2022","unstructured":"Idoudi S, Bedhiafi T, Hijji YM, Billa N (2022) Curcumin and derivatives in nanoformulations with therapeutic potential on colorectal cancer. AAPS PharmSciTech 23(5):115","journal-title":"AAPS PharmSciTech"},{"key":"4835_CR96","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16101332","author":"J Georgeous","year":"2024","unstructured":"Georgeous J, AlSawaftah N, Abuwatfa WH, Husseini GA (2024) Review of gold nanoparticles: synthesis, properties, shapes, cellular uptake, targeting, release mechanisms and applications in drug delivery and therapy. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics16101332","journal-title":"Pharmaceutics"},{"key":"4835_CR97","doi-asserted-by":"publisher","first-page":"7271","DOI":"10.2147\/IJN.S520616","volume":"20","author":"H Xin","year":"2025","unstructured":"Xin H, Chang Z, Niu M (2025) Multifaceted applications of nanomaterials in colorectal cancer management: screening, diagnostics, and therapeutics. Int J Nanomed 20:7271\u20137294","journal-title":"Int J Nanomed"},{"key":"4835_CR98","doi-asserted-by":"crossref","unstructured":"Brar B, Ranjan K, Palria A, Kumar R, Ghosh M, Sihag S et al (2021) Nanotechnology in colorectal cancer for precision diagnosis and therapy. Front Nanatechnol. ;Volume 3\u20132021","DOI":"10.3389\/fnano.2021.699266"},{"issue":"1","key":"4835_CR99","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1080\/21691401.2023.2247036","volume":"51","author":"S Pande","year":"2023","unstructured":"Pande S (2023) Liposomes for drug delivery: review of vesicular composition, factors affecting drug release and drug loading in liposomes. Artif Cells Nanomed Biotechnol 51(1):428\u2013440","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"3","key":"4835_CR100","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1093\/annonc\/mdh097","volume":"15","author":"ME O\u2019Brien","year":"2004","unstructured":"O\u2019Brien ME, Wigler N, Inbar M, Rosso R, Grischke E, Santoro A et al (2004) Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX\/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. Ann Oncol 15(3):440\u2013449","journal-title":"Ann Oncol"},{"issue":"7","key":"4835_CR101","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1093\/annonc\/mdi204","volume":"16","author":"U Jacobi","year":"2005","unstructured":"Jacobi U, Waibler E, Schulze P, Sehouli J, Oskay-Ozcelik G, Schmook T et al (2005) Release of doxorubicin in sweat: first step to induce the palmar-plantar erythrodysesthesia syndrome? Ann Oncol 16(7):1210\u20131211","journal-title":"Ann Oncol"},{"key":"4835_CR102","doi-asserted-by":"crossref","unstructured":"Chai M, Wang S, Chen Y, Pei X, Zhen X (2025) Targeted and intelligent nano-drug delivery systems for colorectal cancer treatment. Front Bioeng Biotechnol. ;Volume 13\u20132025","DOI":"10.3389\/fbioe.2025.1582659"},{"issue":"1","key":"4835_CR103","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-025-00656-1","volume":"14","author":"J Venturini","year":"2025","unstructured":"Venturini J, Chakraborty A, Baysal MA, Tsimberidou AM (2025) Developments in nanotechnology approaches for the treatment of solid tumors. Exp Hematol Oncol 14(1):76","journal-title":"Exp Hematol Oncol"},{"key":"4835_CR104","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2147\/CMAR.S150960","volume":"10","author":"RL Mahtani","year":"2018","unstructured":"Mahtani RL, Parisi M, Gl\u00fcck S, Ni Q, Park S, Pelletier C et al (2018) Comparative effectiveness of early-line nab-paclitaxel vs. paclitaxel in patients with metastatic breast cancer: a US community-based real-world analysis. Cancer Manag Res 10:249\u2013256","journal-title":"Cancer Manag Res"},{"key":"4835_CR105","doi-asserted-by":"publisher","first-page":"7257","DOI":"10.2147\/IJN.S437860","volume":"18","author":"R Bajracharya","year":"2023","unstructured":"Bajracharya R, Baral KC, Lee SH, Song JG, Han HK (2023) Organometallic phyllosilicate-gold nanocomplex: an effective oral delivery system of methotrexate for enhanced in vivo efficacy against colorectal cancer. Int J Nanomed 18:7257\u20137266","journal-title":"Int J Nanomed"},{"issue":"1","key":"4835_CR106","doi-asserted-by":"publisher","DOI":"10.1186\/s40580-022-00310-0","volume":"9","author":"ST Chuang","year":"2022","unstructured":"Chuang ST, Conklin B, Stein JB, Pan G, Lee KB (2022) Nanotechnology-enabled immunoengineering approaches to advance therapeutic applications. Nano Convergence 9(1):19","journal-title":"Nano Convergence"},{"issue":"9","key":"4835_CR107","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.5306\/wjco.v15.i9.1136","volume":"15","author":"H Fadlallah","year":"2024","unstructured":"Fadlallah H, El Masri J, Fakhereddine H, Youssef J, Chemaly C, Doughan S et al (2024) Colorectal cancer: recent advances in management and treatment. World J Clin Oncol 15(9):1136\u20131156","journal-title":"World J Clin Oncol"},{"key":"4835_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-73234-9_1","volume":"1328","author":"Y Panahi","year":"2021","unstructured":"Panahi Y, Saberi-Karimian M, Valizadeh O, Behnam B, Saadat A, Jamialahmadi T et al (2021) Effects of curcuminoids on systemic inflammation and quality of life in patients with colorectal cancer undergoing chemotherapy: A randomized controlled trial. Adv Exp Med Biol 1328:1\u20139","journal-title":"Adv Exp Med Biol"},{"key":"4835_CR109","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1093\/jn\/nxz029","volume":"149","author":"L Howells","year":"2019","unstructured":"Howells L, Iwuji C, Irving G, Barber S, Walter H, Sidat Z et al (2019) Curcumin combined with FOLFOX chemotherapy is safe and tolerable in patients with metastatic colorectal cancer in a randomized phase IIa trial. J Nutr 149:1133\u20131139","journal-title":"J Nutr"},{"key":"4835_CR110","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1158\/1940-6207.CAPR-10-0098","volume":"4","author":"R Carroll","year":"2011","unstructured":"Carroll R, Benya R, Turgeon D, Vareed S, Neuman M, Rodriguez L et al (2011) Phase IIa clinical trial of Curcumin for the prevention of colorectal neoplasia. Cancer Prev Res 4:354\u2013364","journal-title":"Cancer Prev Res"},{"issue":"1","key":"4835_CR111","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1158\/1055-9965.120.14.1","volume":"14","author":"G Garcea","year":"2005","unstructured":"Garcea G, Berry DP, Jones DJ, Singh R, Dennison AR, Farmer PB et al (2005) Consumption of the putative chemopreventive agent Curcumin by cancer patients: assessment of Curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidemiol Biomarkers Prev 14(1):120\u2013125","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"4835_CR112","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3109\/07357907.2010.550592","volume":"29","author":"ZY He","year":"2011","unstructured":"He ZY, Shi CB, Wen H, Li FL, Wang BL, Wang J (2011) Upregulation of p53 expression in patients with colorectal cancer by administration of curcumin. Cancer Invest 29(3):208\u2013213","journal-title":"Cancer Invest"},{"issue":"1","key":"4835_CR113","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00280-016-3193-5","volume":"79","author":"M Ducreux","year":"2017","unstructured":"Ducreux M, Bennouna J, Adenis A, Conroy T, Li\u00e8vre A, Portales F et al (2017) Efficacy and safety of nab-paclitaxel in patients with previously treated metastatic colorectal cancer: a phase II COLO-001 trial. Cancer Chemother Pharmacol 79(1):9\u201316","journal-title":"Cancer Chemother Pharmacol"},{"issue":"9","key":"4835_CR114","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/S1470-2045(17)30457-6","volume":"18","author":"HS Wasan","year":"2017","unstructured":"Wasan HS, Gibbs P, Sharma NK, Taieb J, Heinemann V, Ricke J et al (2017) First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials. Lancet Oncol 18(9):1159\u20131171","journal-title":"Lancet Oncol"},{"issue":"14","key":"4835_CR115","doi-asserted-by":"publisher","first-page":"3850","DOI":"10.1073\/pnas.1603018113","volume":"113","author":"AJ Clark","year":"2016","unstructured":"Clark AJ, Wiley DT, Zuckerman JE, Webster P, Chao J, Lin J et al (2016) CRLX101 nanoparticles localize in human tumors and not in adjacent, nonneoplastic tissue after intravenous dosing. Proc Natl Acad Sci U S A 113(14):3850\u20133854","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"4835_CR116","doi-asserted-by":"publisher","first-page":"962","DOI":"10.21037\/jgo.2017.08.10","volume":"8","author":"J Chao","year":"2017","unstructured":"Chao J, Lin J, Frankel P, Clark AJ, Wiley DT, Garmey E et al (2017) Pilot trial of CRLX101 in patients with advanced, chemotherapy-refractory gastroesophageal cancer. J Gastrointest Oncol 8(6):962\u2013969","journal-title":"J Gastrointest Oncol"},{"key":"4835_CR117","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13101715","author":"R Tabanelli","year":"2021","unstructured":"Tabanelli R, Brogi S, Calderone V (2021) Improving curcumin bioavailability: current strategies and future perspectives. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics13101715","journal-title":"Pharmaceutics"},{"key":"4835_CR118","doi-asserted-by":"crossref","unstructured":"Shafei LKIA, Mohamed Ibrahim MI, Billa N (2021) Is Curcumin at the threshold of therapeutic effectiveness on patients with colon Cancer?\u2014A systematic review. Front Pharmacol. ;Volume 12\u20132021","DOI":"10.3389\/fphar.2021.707231"},{"issue":"20","key":"4835_CR119","doi-asserted-by":"publisher","first-page":"6847","DOI":"10.1158\/1078-0432.CCR-04-0744","volume":"10","author":"RA Sharma","year":"2004","unstructured":"Sharma RA, Euden SA, Platton SL, Cooke DN, Shafayat A, Hewitt HR et al (2004) Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 10(20):6847\u20136854","journal-title":"Clin Cancer Res"},{"key":"4835_CR120","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.846282","volume":"9","author":"L Liu","year":"2022","unstructured":"Liu L, Yang S, Chen F, Cheng K-W (2022) Polysaccharide-zein composite nanoparticles for enhancing cellular uptake and oral bioavailability of curcumin: characterization, anti-colorectal cancer effect, and pharmacokinetics. Front Nutr 9:846282","journal-title":"Front Nutr"},{"key":"4835_CR121","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.21037\/jgo-22-259","volume":"13","author":"J Gunther","year":"2022","unstructured":"Gunther J, Chadha A, Guha S, Raju G, Maru D, Munsell M et al (2022) A phase II randomized double blinded trial evaluating the efficacy of Curcumin with pre-operative chemoradiation for rectal cancer. J Gastrointest Oncol 13:2938\u20132950","journal-title":"J Gastrointest Oncol"},{"key":"4835_CR122","unstructured":"Abad MJY, Allahyari A, Kamandi M, Arasteh O, Varmaghani M, Karbasforooshan H et al (2025) Evaluation of Nano-curcumin oral formulation efficacy as an adjuvant treatment in metastatic colorectal patients. J Pharm Care"},{"key":"4835_CR123","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.846282","author":"L Liu","year":"2022","unstructured":"Liu L, Yang S, Chen F, Cheng K-W (2022) Polysaccharide-zein composite nanoparticles for enhancing cellular uptake and oral bioavailability of curcumin: characterization, anti-colorectal cancer effect, and pharmacokinetics. Front Nutr. https:\/\/doi.org\/10.3389\/fnut.2022.846282","journal-title":"Front Nutr"},{"key":"4835_CR124","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.4988","author":"L Xu","year":"2020","unstructured":"Xu L, Tang X, Zhang G, Yuan D (2020) Metabolic profile of Curcumin self-emulsifying drug delivery system in rats determined by ultra-high performance liquid chromatography\/quadrupole time-of-flight mass spectrometry. Biomed Chromatogr. https:\/\/doi.org\/10.1002\/bmc.4988","journal-title":"Biomed Chromatogr"},{"issue":"1","key":"4835_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e12829","volume":"9","author":"C Wang","year":"2023","unstructured":"Wang C, Jiang X, Zhang X, Xu Y, Li L, Li X et al (2023) A novel solvent-free co-grinding preparation improves Curcumin bioavailability in healthy volunteers: a single-center crossover study. Heliyon 9(1):e12829","journal-title":"Heliyon"},{"issue":"4","key":"4835_CR126","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00280-018-3654-0","volume":"82","author":"R Greil","year":"2018","unstructured":"Greil R, Greil-Ressler S, Weiss L, Sch\u00f6nlieb C, Magnes T, Radl B et al (2018) A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc(\u2122)) in patients with locally advanced or metastatic cancer. Cancer Chemother Pharmacol 82(4):695\u2013706","journal-title":"Cancer Chemother Pharmacol"},{"issue":"5","key":"4835_CR127","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1111\/cas.14383","volume":"111","author":"H Ozawa-Umeta","year":"2020","unstructured":"Ozawa-Umeta H, Kishimoto A, Imaizumi A, Hashimoto T, Asakura T, Kakeya H et al (2020) Curcumin \u03b2-D-glucuronide exhibits anti-tumor effects on oxaliplatin-resistant colon cancer with less toxicity in vivo. Cancer Sci 111(5):1785\u20131793","journal-title":"Cancer Sci"},{"key":"4835_CR128","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17030395","author":"B Zhang","year":"2025","unstructured":"Zhang B, Guo W, Chen Z, Chen Y, Zhang R, Liu M et al (2025) Physicochemical characterization and oral bioavailability of curcumin\u2013phospholipid complex nanosuspensions prepared based on microfluidic system. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics17030395","journal-title":"Pharmaceutics"},{"key":"4835_CR129","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00152","volume":"10","author":"KE Wong","year":"2019","unstructured":"Wong KE, Ngai SC, Chan KG, Lee LH, Goh BH, Chuah LH (2019) Curcumin nanoformulations for colorectal cancer: a review. Front Pharmacol 10:152","journal-title":"Front Pharmacol"},{"key":"4835_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.cis.2021.102582","volume":"300","author":"F Da Silva Feltrin","year":"2021","unstructured":"Da Silva Feltrin F, Agner T, Sayer C, Lona L (2021) Curcumin encapsulation in functional PLGA nanoparticles: a promising strategy for cancer therapies. Adv Colloid Interface Sci 300:102582","journal-title":"Adv Colloid Interface Sci"},{"key":"4835_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.111704","volume":"183","author":"PY Khor","year":"2019","unstructured":"Khor PY, Aluwi MFFM, Rullah K, Lam KW (2019) Insights on the synthesis of asymmetric Curcumin derivatives and their biological activities. Eur J Med Chem 183:111704","journal-title":"Eur J Med Chem"},{"key":"4835_CR132","doi-asserted-by":"crossref","unstructured":"Oskuee RK, Gholami L, Momtazi-Borojeni A, Malaekeh-Nikouei B, Nikfar B, Amanolahi F et al (2023) Selective cellular uptake and cytotoxicity of Curcumin-encapsulated SPC and HSPC liposome nanoparticles on human bladder cancer cells. Current pharmaceutical design","DOI":"10.2174\/1381612829666230331084848"},{"issue":"3","key":"4835_CR133","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/mnfr.201300724","volume":"58","author":"C Schiborr","year":"2014","unstructured":"Schiborr C, Kocher A, Behnam D, Jandasek J, Toelstede S, Frank J (2014) The oral bioavailability of Curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes. Mol Nutr Food Res 58(3):516\u2013527","journal-title":"Mol Nutr Food Res"},{"issue":"1","key":"4835_CR134","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/ijc.22645","volume":"121","author":"LM Howells","year":"2007","unstructured":"Howells LM, Mitra A, Manson MM (2007) Comparison of oxaliplatin\u2010and curcumin\u2010mediated antiproliferative effects in colorectal cell lines. Int J Cancer 121(1):175\u2013183","journal-title":"Int J Cancer"},{"key":"4835_CR135","doi-asserted-by":"publisher","DOI":"10.3390\/cells13110957","author":"CK Valiveti","year":"2024","unstructured":"Valiveti CK, Kumar B, Singh AD, Biradar SK, Ahmad R, Singh AB et al (2024) Stable dietary Ora-curcumin formulation protects from experimental colitis and colorectal cancer. Cells. https:\/\/doi.org\/10.3390\/cells13110957","journal-title":"Cells"},{"issue":"1","key":"4835_CR136","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.bmcl.2013.12.011","volume":"24","author":"L Fang","year":"2014","unstructured":"Fang L, Gou S, Liu X, Cao F, Cheng L (2014) Design, synthesis and anti-Alzheimer properties of dimethylaminomethyl-substituted curcumin derivatives. Bioorg Med Chem Lett 24(1):40\u201343","journal-title":"Bioorg Med Chem Lett"},{"key":"4835_CR137","doi-asserted-by":"crossref","unstructured":"Wahnou H, Kebbaj RE, Liagre B, Sol V, Limami Y, Duval R (2025) Curcumin-Based nanoparticles: advancements and challenges in tumor therapy. Pharmaceutics. ;17","DOI":"10.3390\/pharmaceutics17010114"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-025-04835-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-025-04835-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-025-04835-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T07:01:38Z","timestamp":1766991698000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00280-025-04835-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":137,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4835"],"URL":"https:\/\/doi.org\/10.1007\/s00280-025-04835-z","relation":{},"ISSN":["1432-0843"],"issn-type":[{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"2"}}